Remove Drug Development Remove Labelling Remove Process Improvement
article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

These sessions provide insight into how drugs function in real-world conditions—information that is vital to determining whether a treatment’s price reflects its true value across various patient populations. Food and Drug Administration, FDA Patient-Focused Drug Development Guidance Series , March 21, 2025.